NeuroVision Imaging Inc. Announces Additional Funding From the ADDF to Accelerate Development of Novel Blood-Based Lab Test to Predict Dementia Before Clinical Onset

NeuroVision Imaging Inc. has received an additional investment from the Alzheimer’s Drug Discovery Foundation to hasten development of a novel blood-based lab test to provide detection and measurement of biomarkers for Alzheimer’s disease and other dementias before clinical onset.